Long Road Investment Counsel’s AbbVie ABBV Stock Holding History

Long Road Investment Counsel’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.38M	Buy	6,335 +696	+12%	+$154K	0.54%	43
2025 Q4	$1.29M	Sell	5,639 -336	-6%	-$76.5K	0.49%	44
2025 Q3	$1.38M	Hold	5,975	–	–	0.49%	46
2025 Q2	$1.11M	Hold	5,975	–	–	0.41%	49
2025 Q1	$1.25M	Buy	5,975 +500	+9%	+$97.2K	0.49%	44
2024 Q4	$973K	Hold	5,475	–	–	0.4%	49
2024 Q3	$1.08M	Hold	5,475	–	–	0.43%	48
2024 Q2	$939K	Hold	5,475	–	–	0.41%	47
2024 Q1	$997K	Hold	5,475	–	–	0.42%	49
2023 Q4	$900K	Hold	5,475	–	–	0.37%	49
2023 Q3	$816K	Hold	5,475	–	–	0.4%	50
2023 Q2	$738K	Hold	5,475	–	–	0.34%	52
2023 Q1	$873K	Sell	5,475 -1,360	-20%	-$208K	0.42%	49
2022 Q4	$1.1M	Sell	6,835 -240	-3%	-$36.8K	0.55%	42
2022 Q3	$950K	Hold	7,075	–	–	0.52%	42
2022 Q2	$1.08M	Buy	7,075 +1,140	+19%	+$174K	0.56%	42
2022 Q1	$962K	Sell	5,935 -1,140	-16%	-$166K	0.43%	51
2021 Q4	$958K	Hold	7,075	–	–	0.38%	53
2021 Q3	$763K	Hold	7,075	–	–	0.34%	55
2021 Q2	$797K	Hold	7,075	–	–	0.35%	54
2021 Q1	$766K	Sell	7,075 -200	-3%	-$21.4K	0.35%	54
2020 Q4	$780K	Buy	7,275 +1,600	+28%	+$154K	0.38%	52
2020 Q3	$497K	Sell	5,675 -1,600	-22%	-$151K	0.28%	55
2020 Q2	$714K	Buy	7,275 +31	+0.4%	+$2.73K	0.42%	51
2020 Q1	$552K	Buy	7,244 +1,600	+28%	+$136K	0.39%	55
2019 Q4	$500K	Sell	5,644 -7,176	-56%	-$596K	0.3%	56
2019 Q3	$971K	Buy	12,820 +26	+0.2%	+$1.78K	0.56%	46
2019 Q2	$930K	Hold	12,794	–	–	0.55%	48
2019 Q1	$1.03M	Buy	12,794 +1,600	+14%	+$131K	0.63%	44
2018 Q4	$1.03M	Hold	11,194	–	–	0.79%	38
2018 Q3	$1.06M	Hold	11,194	–	–	0.7%	43
2018 Q2	$1.04M	Sell	11,194 -900	-7%	-$87.9K	0.74%	44
2018 Q1	$1.15M	Sell	12,094 -900	-7%	-$98.9K	0.8%	41
2017 Q4	$1.26M	Hold	12,994	–	–	0.87%	39
2017 Q3	$1.16M	Hold	12,994	–	–	0.82%	39
2017 Q2	$942K	Hold	12,994	–	–	0.69%	45
2017 Q1	$847K	Hold	12,994	–	–	0.62%	45
2016 Q4	$814K	Hold	12,994	–	–	0.63%	45
2016 Q3	$820K	Hold	12,994	–	–	0.63%	47
2016 Q2	$804K	Hold	12,994	–	–	0.63%	46
2016 Q1	$742K	Hold	12,994	–	–	0.58%	48
2015 Q4	$770K	Hold	12,994	–	–	0.63%	43
2015 Q3	$707K	Hold	12,994	–	–	0.6%	44
2015 Q2	$873K	Buy	12,994 +200	+2%	+$13.1K	0.71%	40
2015 Q1	$749K	Buy	12,794 +1,800	+16%	+$109K	0.64%	41
2014 Q4	$719K	Buy	+10,994	New	+$693K	0.65%	40

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Long Road Investment Counsel's ABBV Position: Q1 2026 in Review

Long Road Investment Counsel increased its AbbVie (ABBV) stake by 12% in Q1 2026, buying an estimated $154K and bringing the position to 6,335 shares worth $1.38M. The position accounts for 0.54% of the portfolio, ranked #43.

Long Road Investment Counsel first reported a position in ABBV in Q4 2014 and has held it in 46 quarters since. The position peaked at $1.38M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Long Road Investment Counsel held 6,335 shares of AbbVie worth $1.38M as of Q1 2026.
Long Road Investment Counsel bought 696 AbbVie shares in Q1 2026, an estimated $154K.
AbbVie made up 0.54% of Long Road Investment Counsel's portfolio in Q1 2026, its #43 holding.
Long Road Investment Counsel first reported a position in AbbVie in Q4 2014 and has held it in 46 quarters since.
Long Road Investment Counsel's AbbVie position peaked at $1.38M in Q3 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Long Road Investment Counsel's 13F filing for Q1 2026, filed 8 May 2026.